* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Clinical Microbiology and Infection
Childhood immunizations in the United States wikipedia , lookup
Neglected tropical diseases wikipedia , lookup
Traveler's diarrhea wikipedia , lookup
Plant disease resistance wikipedia , lookup
Sociality and disease transmission wikipedia , lookup
Gastroenteritis wikipedia , lookup
Staphylococcus aureus wikipedia , lookup
Common cold wikipedia , lookup
Hepatitis B wikipedia , lookup
Human cytomegalovirus wikipedia , lookup
Carbapenem-resistant enterobacteriaceae wikipedia , lookup
Transmission (medicine) wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Urinary tract infection wikipedia , lookup
Anaerobic infection wikipedia , lookup
Infection control wikipedia , lookup
Clinical Microbiology and Infection VOLUME 11, SUPPLEMENT 2, APRIL 2005 15th European Congress of Clinical Microbiology and Infectious Diseases Copenhagen, Denmark 2–5 April 2005 Page 1 1 3 3 4 4 5 6 6 7 8 8 9 9 14 17 18 20 23 23 23 24 24 26 28 30 31 32 33 33 38 Antibiotic sensitivity testing of anaerobic bacteria – Workshop arranged by ESGARAB History of medical microbiology in Denmark Update on toxoplasmosis (Symposium arranged with ESGT) European guidelines for diagnosis of tick borne diseases (Symposium arranged with ESCAR) Vancomycin- and methicillin-resistant Staphylococcus aureus (VMRSA): how to cope with it in the hospital setting? (Symposium arranged with ESGNI) Management of relapses and outbreaks of Clostridium difficile (Symposium arranged with ESGCD) Antibiotics for lower respiratory tract infections in primary care (Symposium arranged with ESPRIT) Antibiotic use and policies: an in-depth look at ARPAC results (Symposium arranged with ESGAP) Is the commensal anaerobic microflora involved in spreading antibiotic resistance? (Symposium arranged with ESGARAB) Malaria control – what is in the pipeline? Pseudomonas aeruginosa: a rogue bacterium in the intensive care unit (Symposium arranged with ESICM) Tuberculosis: persistence and resistance Clinical microbiology: what’s new in conventional and molecular diagnostics? (Symposium arranged with ESGMD) Antibiotic usage: practices and policy interventions Hepatitis virus From mild to severe respiratory tract infection: what’s new with azalides? (Symposium arranged by PLIVA) Emerging viral infections Advances in febrile neutropenia The impact of beta-lactamases on clinical practice The year in HIV medicine Coping with the severe acute respiratory syndrome Advances in foreign body infections Paediatric infections New typing approaches for MRSA control Pharmacokinetics and pharmacodynamics of antibiotics Genetic typing for important viral infections: recent technological and conceptual developments (Symposium arranged with ESGEM) Modifying the ribosome as a mechanism of resistance (Joint symposium arranged with ICAAC) Patterns of antibiotic stewardship, use and resistance in European hospitals (Joint symposium arranged with ARPAC and ESAC) Combination antifungal therapy (Symposium arranged with EFISG) New diagnostic methods for the laboratory Hospital infection: new sources and solutions Contents 41 43 44 44 48 52 55 56 56 56 57 58 59 59 60 62 62 66 69 73 74 75 76 77 81 85 88 89 89 90 90 92 93 93 94 99 106 114 123 127 133 136 143 148 159 163 165 171 174 182 190 200 205 212 216 221 230 New antibacterials for the decade: strategies to deliver agents with novel actions (Symposium arranged by GlaxoSmithKline) Staphylococcus aureus disease – from basic science to clinical practice Benchmarking nosocomial infections (Symposium co-organised by SHEA and ESGNI) Exotic infections Emergence and molecular evolution of antibiotic resistance Predictors of the clinical course of HIV infection and therapy Antimicrobial growth promoters in food animal production Crosstalk between bacterial pathogens and their host cells Infection control: challenges now and ahead Burkholderia, Pseudomonas and emerging infections in cystic fibrosis Climate and environment: impact on infectious diseases Crimean Congo haemorrhagic fever in south-eastern Europe Computerised decision support for management of bacterial infections Hepatitis C virus: new targets for drug and vaccine development and markers for therapy Focus on Mycobacterium tuberculosis Diagnosis and management of sepsis in the critically-ill patient (Symposium arranged with ISF) MRSA – new challenges in hospital and community settings Focus on extraction and amplification controls in molecular diagnostics New developments in epidemiology of antibiotic resistance Bacterial biofilms Focus on new antibacterials Emerging infections in the immuno-compromised host (Symposium arranged with EORTC/ IDSG) Community-acquired MRSA in Europe – evolution at work Recent trends in severe fungal infections Antibiotic and antibiotic resistance mechanisms Infections in the community: epidemiology, diagnosis and outcome Metallo-beta-lactamases: a last frontier for beta-lactams? Social-political consequences of the HIV pandemic: are we turning the tide? Evolution and function of the haemagglutinin of the influenza virus Streptococcus pneumoniae: a clonal war? Recent advances in chlamydiology Resistance to antifungal drugs Emerging enteric pathogens: responding to the challenge Influenza vaccination New drugs to fight the resistance challenge Metallo-beta-lactamases and resistance to carbapenems Epidemiology of ESBL and MBL – I Extended-spectrum beta-lactamase and other beta-lactamases Various antimicrobial agents including disinfectants Urinary tract infections Borrelia Antibiotic usage Antibiotic policy intervention Tuberculosis: diagnosis, resistance and immunology Brucella Toxoplasmosis Clinical mycology Clinical use of vaccines Molecular methods for respiratory bacterial pathogens Molecular methods for enteric pathogens HIV HCV: risk factors, diagnosis, clinical presentation and treatment Bacteriology: role of selective media and identification systems 16S rRNA Clinical mycology: case reports Enterococci: epidemiology and resistance Epidemiology of ESBL and MBL – II Contents 238 246 253 259 264 266 271 280 284 291 292 299 302 314 326 328 334 338 341 346 350 354 361 366 376 381 388 391 401 408 411 414 423 435 439 442 449 456 461 469 478 483 486 489 494 499 504 514 516 519 524 527 531 536 546 551 554 561 563 569 Tigecycline, in vitro studies Sexually transmitted diseases Helicobacter MRSA – virulence, genes, VISA and treatment Training, scientific output in infectious disease Pneumonia Pharmacokinetics/pharmacodynamics of antibacterial drugs Organ transplants Exotic infections – I: case series Infection and immunopathology Staphylococcal infections Mechanisms of resistance in staphylococci Typing and epidemiology of MRSA Antibiotic-resistant pneumococci and streptococci Wound and fungal infections Antibiotic resistance: nosocomial pathogens Difficult to treat nosocomial infections Susceptibility surveillance studies Pharmacokinetics/pharmacodynamics of quinolones Pharmacokinetics/pharmacodynamics of antifungals Infection control: environmental and hand disinfection Exotic infections – II Fungal susceptibility testing Skin and soft tissue infections Fluroquinolones, in vitro studies Antibacterial susceptibility studies – I Mechanisms of resistance to macrolides Paediatric infections Mechanisms of antibiotic resistance in Gram-negative bacilli Public health, surveillance and geographic information systems Endocarditis Enteric infection Respiratory tract infection Pneumococcal pneumonia Pneumonia in non-HIV immunosuppressed patients Detection of methicillin resistance Infections and diagnosis in non-HIV immunosuppressed patients Mechanisms of resistance to quinolones Antibacterial susceptibility studies – II Antibiotic-resistant community-acquired pathogens – I Fungal diagnostics ELISA-based diagnostics Clostridium difficile Chlamydia trachomatis Hepatitis A, B and E viruses Herpes virus New drugs: in vitro studies New drugs: in vivo studies Pharmacokinetics/pharmacodynamics of anti-staphyloccal drugs Infections in neutropenic patients Procalcitonin, other markers of infection Diagnosis of viral infections: new methods Diagnosis of viral infections: respiratory and herpes viruses Biofilms: pathogenesis and antibiotic susceptibility CNS infections Experimental CNS infections Bloodstream infection Catheter-related infections Molecular bacteriology and mycology Antifungal susceptibility studies Contents 575 583 585 592 597 609 616 622 628 634 636 648 651 651 654 659 661 667 673 685 692 695 697 699 706 710 718 720 722 724 725 730 734 737 739 742 742 745 771 Pathogenesis of respiratory tract and other infections Adverse drug reactions, probiotics Antibiotic-resistant community-acquired pathogens – II Pathogenesis of infections Non-fermenter Gram-negative bacilli: epidemiology and resistance Immunology, host defences, immunotherapy Antibiotic resistance: nosocomial pathogens Susceptibility testing methods Surveillance of nosocomial infections Environmental impact on nosocomial infections Tuberculosis: clinical aspects and surveillance Health care issues, public health, pharmaco-economics New drugs Pharmacokinetics, pharmacodynamics, drug interactions, tolerability In vitro activity of antimicrobial agents Mechanisms of action and of resistance of antimicrobial drugs Epidemiology of resistance, antibiotic usage Community-acquired infections Nosocomial infections, infection control Infection in the immunocompromised host (except HIV) Immunology, host defenses, immunotherapy Pathogenesis, animal models including experimental treatment Molecular bacteriology (incl. diagnostics) Diagnostic methods (other than molecular) Mycobacterial infections (incl. diagnostics) Fungal infections Tropical and parasitic diseases Sexually transmitted diseases (except HIV) Molecular virology (incl. diagnostics) Viral diseases (not HIV, Herpes, Hepatitis) AIDS and HIV infection Hepatitis Herpes virus Emerging infectious diseases Vaccines Infection in transplant recipients Paediatric infections Author index Subject index